Overview

Novel Topical Therapies for the Treatment of Genital Pain

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Rochester
Collaborator:
Mae Stone Goode Foundation
Treatments:
Amitriptyline
Amitriptyline, perphenazine drug combination
Antidiarrheals
Baclofen
Gabapentin
Ketamine
Ketoprofen
Loperamide